Bright News

Mumbai, 3 August, 2026: Mumbai-based Encube Ethicals Limited has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Initial Public Offering (IPO). The IPO, with a face value of Re 1, is a complete offer for sale of Rs 3000 crore by promoters – Mehul Madhusudan Shah, and Investor Selling Shareholder - Frontier Investment Holdings Pte. Ltd. The issue is being made through the book-building process, in line with SEBI ICDR Regulations, wherein not more than 50% reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for Retail Individual Investors (RIIs). About the Company Incorporated in 1995, the company is global specialty pharmaceutical formulations platform with deep domain expertise in technically complex topical and transdermal dosage forms, serving 50 countries including regulated markets such as the United States, UK and Euro...

Price band of ₹ 151– ₹ 159 per Equity Share bearing face value of ₹ 1 each “Equity Shares” Bid/Offer Opening Date – Friday, August 07, 2026 and Bid/Offer Closing Date – Tuesday, August 11, 2026. Minimum Bid Lot is 94 Equity Shares and in multiples of 94 Equity Shares thereafter Mumbai, August 03, 2026 : LEAP India Limited has fixed the price band of  ₹  151/- to  ₹  159/- per Equity Share of face value ₹ 1/- each for the initial public offer of its Equity Shares of face value ₹ 1/- each (“IPO” or “Offer”).  The IPO of the Company will open on Friday, August 07, 2026, for subscription and close on Tuesday, August 11, 2026. Investors can bid for a minimum of 94 Equity Shares and in multiples of 94 Equity Shares thereafter. The issued, subscribed and paid-up shared capital of the Company before the Offer comprises 410,347,780 Equity Shares of ₹ 1 each The Offer, comprises of a Fresh Issue of such number of Equity Shares aggregating up to ₹  4,800 million and a...